GlassScriptPhysician profile
Christopher Buckley
NPI 1255358917
$1,412.97
in general payments reported to CMS, 2019-2025
33 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $78.03 · 2021: $72.71 · 2022: $186 · 2023: $135 · 2024: $349 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Education: $94.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.22 |
| Education | $94.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $260.67 | 2019-2025 | Veozah |
| Sage Therapeutics, LLC | $212.46 | 2019-2025 | Zurzuvae |
| Abbvie INC. | $193.00 | 2019-2025 | Ubrelvy, Lo Loestrin Fe |
| Pfizer INC. | $67.43 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.49 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $49.45 | 2024 | Exparel, Zilretta, Iovera |
| Organon LLC | $48.67 | 2021-2025 | Nexplanon |
| Aspira Women'S Health INC | $46.71 | 2022 | |
| Mayne Pharma Commercial LLC | $40.16 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $34.98 | 2021-2025 | Gardasil 9 |
| Duchesnay USA Incorporated | $25.46 | 2019 | |
| Biogen, INC. | $24.17 | 2023 | |
| Amag Pharmaceuticals, INC. | $24.17 | 2019 | |
| Hologic Sales and Service, LLC | $22.77 | 2023 | Aptima, Thinprep 2000 Processor |
| Ethicon US, LLC | $22.14 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $21.27 | 2023 | Summit Doppler |
| Meditrina | $21.10 | 2019-2023 | |
| Coloplast Corp | $20.24 | 2022 | |
| Baxter Healthcare | $19.42 | 2020 | |
| Innovation Technologies INC | $17.56 | 2025 | Irrisept |
| Myovant Sciences INC. | $16.68 | 2021 | |
| Daiichi Sankyo INC. | $16.61 | 2020 | |
| Amgen INC. | $15.81 | 2019 | |
| Sumitomo Pharma America, INC. | $15.75 | 2024 | Myfembree |
| Convatec INC. | $15.59 | 2019 | |
| Kerecis Limited | $14.88 | 2022 | |
| Covidien LP | $14.21 | 2019 | |
| Exact Sciences Corporation | $14.06 | 2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $13.87 | 2022 | |
| Roche Diagnostics Corporation | $13.75 | 2019 | |
| Exeltis, USA INC. | $13.48 | 2024 | Slynd |
| Boston Scientific Corporation | $12.78 | 2022 | |
| Biom'Up Sa | $10.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.